Oxidatively modified low-density lipoprotein (OxLDL) is present in atherosclerotic lesions and has been proposed to play an important role in atherogenesis. In the present study, in order to clarify the structure-binding activity relationship of Asp-hemolysin-related peptides to OxLDL, we investigated the interaction between Asphemolysin-related peptides consisting of 4 to 29 amino acid residues and OxLDL. The incubation of OxLDL with each Asp-hemolysin-related peptide resulted in the formation of an Asp-hemolysin/OxLDL complex. In particular, the tetrapeptide, YKDG (P-4), bound to OxLDL and inhibited the OxLDL-induced macrophage proliferation in a dose-dependent manner. Furthermore, we demonstrated that lysophosphatidylcholine (LysoPC) extracted from OxLDL inhibited the binding of P-21 to OxLDL in a dose-dependent manner and synthetic [ 14 C]LysoPC bound to P-21. We propose here that the YKDG region is one of the important sites for the binding of these peptides to OxLDL, and LysoPC as a typical lipid moiety of OxLDL is attributed to the binding of OxLDL to these peptides.
occurring together with apoptotic and necrotic cell death within an atherosclerotic lesion.
3) Low-density lipoproteins (LDL) are believed to play a major role in the pathogenesis of atherosclerosis, whereas the oxidation of LDL seems to be an essential step. [4] [5] [6] Oxidized LDL (OxLDL) is known to have various atherogenic effects, such as acting as a chemoattractant for circulating monocytes, 7) impairing endothelium-dependent arterial relaxation, 8) and is cytotoxic to endothelial cells. 9) In addition, Sakai et al. described a new property for OxLDL, the induction of macrophage proliferation, 10) in which lysophosphatidylcholine (LysoPC), a major phospholipid component of OxLDL, plays an important role in its mitogenic effect. 11, 12) The mechanisms by which OxLDL increases atherogenicity are not yet fully explained, but its major component, LysoPC, appears to be responsible for most of the effects of OxLDL. 13) Asp-hemolysin is a hemolytic toxin from Aspergillus fumigatus. 14) The gene for Asp-hemolysin has been cloned and the gene sequence has been reported. 15) The sequence of the primary Asp-hemolysin gene product, predicted from the cDNA sequence, consists of 131 amino acid residues and has a molecular mass of 14275. We have previously reported that OxLDL inhibits the hemolytic activity of Asp-hemolysin and Asp-hemolysin binds to OxLDL in a concentration-dependent manner. 16, 17) We recently showed that Asp-hemolysin is a specific binding protein for OxLDL with high affinity (KDϭ0.63 mg/ml), and its binding specificity is distinct from any receptor for OxLDL. 18) In addition, we demonstrated that the LysoPC is involved in the binding of Asp-hemolysin to OxLDL, and that Asp-hemolysin is a binding protein for LysoPC. 19 ) Moreover, we recently reported that the Asp-hemolysin-related peptide (P-21), a synthetic peptide derived from a region of Asp-hemolysin that is rich in positive charges, inhibits the OxLDL-induced macrophage proliferation through binding of P-21 to OxLDL. 20) The aim of this study was to clarify the structure-binding activity relationships of Asp-hemolysin-related peptides to OxLDL. We investigated the interactions between Asphemolysin-related peptides consisting of 4 to 29 amino acid residues and OxLDL. In this paper, we revealed that the YKDG sequence of Asp-hemolysin-related peptides is necessary for the binding of these peptides to OxLDL, and LysoPC as a typical lipid moiety of OxLDL is attributable to the binding of OxLDL to the Asp-hemolysin-related peptide.
MATERIALS AND METHODS

Synthetic Peptide
Asp-hemolysin-related peptides and its N-terminally biotinylated peptides were synthesized by Bio synthesis Inc. (Lewisville, Texas, U.S.A.). The primary sequences of the peptides used in this study are shown in Table 1 . These peptides were purified by reverse HPLC and subsequently analyzed by laser desorption mass spectrometry. The amino acid sequence of these peptides were analyzed by the Chou-Fasman algorithm 21) using the GENETYX-MAC program (GENETYX corporation) and the three-dimensional/one-dimensional (3D-1D) compatibility methods using LIBLA-1 program (DNA data bank of Japan) 22) for prediction of secondary structures.
Preparation and Modification of LDL Human LDL (dϭ1.019Ϫ1.063 g/ml) was isolated by sequential ultracentrifugation from fresh plasma collected in EDTA (1 mg/ml) as previously described.
23) The protein content of the LDL was assayed using the method of Lowry et al. with bovine serum albumin (BSA) as the standard. 24) LDL was oxidized by incubation with 5 mM CuSO 4 in phosphate-buffered saline (PBS) without EDTA at 37°C for specified time intervals at a protein concentration of 200 mg/ml. Oxidation was arrested by refrigeration and the addition of 300 mM EDTA and 25 mM butylated hydroxytoluene (BHT). All OxLDL samples were oxidized for 4 h unless noted otherwise. In some experiments, LDL was isolated by sequential ultracentrifugation from fresh plasma collected in 1 mg/ml EDTA and 50 mM BHT, and then LDL and BHT-containing LDL were stored in an air atmosphere for 14 d to auto-oxidation (auto-oxidized LDL).
Assay and Extraction of LysoPC from OxLDL Phospholipids from OxLDL were extracted with chloroform/ methanol (1 : 1). Two milliliters of chloroform and 2 ml of methanol were added to 2 mg of OxLDL in a total volume of 1.8 ml of 10 mM PBS containing 0.01 M HCl. After vortex mixing for 10 s, the mixture was centrifuged at 1800ϫg for 10 min. The chloroform phase was collected and dried under a stream of nitrogen. The dried lipids were redissolved in chloroform/methanol (2 : 1) and subjected to thin-layer chromatography (TLC) on HPTLC plates (silica gel 60, Merck) using chloroform/methanol/acetic acid/water (25 : 15 : 4:2). The bands on the TLC were visualized with primulin reagent (Wako). The LysoPC zone was scraped into test tubes, and assayed for phosphorus content. The phospholipid levels were determined using a commercial kit (Wako).
Western Blot Analysis The binding assay of each peptide to OxLDL was performed by immunoblotting. Each biotinylated peptide (10 mg) was incubated with OxLDL (5 mg) in 26 ml of PBS at 37°C for 30 min. After incubation, the reaction mixture was subjected to 4% nondenaturing polyacrylamide gel electrophoresis (PAGE) for separating the bound and free biotinylated peptide. Gels were either stained with Coomassie brilliant blue R-250 or transferred to Immobilon P (Millipore). The membrane was blocked with 0.05% Tween-20, 150 mM NaCl in 50 mM Tris-HCl, pH 7.4 (TTBS) included 5% BSA for 2 h and then shaken with 1 : 1000 streptavidin-biotinylated horseradish peroxidase complex (Wallac Oy) for 30 min. Immunodetection was performed with the enhanced chemiluminescence (ECL) Western blot detection kit (Amersham bioscience). In addition, OxLDL was subjected to 4% nondenaturing PAGE and transferred to Immobilon P. The membrane was blocked with 5% BSA in TTBS and incubated with 1 : 3000 anti-human b-lipoprotein IgG fractions (Nippon Biotest Labo.) for 12 h. Immunodetection using the goat anti-rabbit IgG Fc antibody (MP Biomedicals) and rabbit peroxidase anti-peroxidase complex (MP Biomedicals) was performed as described above. The experiments presented were the representatives of at least 3 separate experiments.
In some experiments, auto-oxidized LDL, prepared and stored for 14 d without BHT as antioxidative reagent, was incubated with biotinylated P-4 in the absence or presence of unlabelled P-4 (10-50 mg), and then binding assays of the reaction mixtures were also performed.
Cell Culture Resident peritoneal macrophages were collected from male ddY mice by peritoneal lavage with icecold Ca 2ϩ -free Hanks balanced salt solution (Invitrogen life technologies). Cells were resuspended in AIM V ® medium (Invitrogen life technologies) and adjusted to 5ϫ10 4 cells/ml for [ 3 H]thymidine incorporation assay, and 5ϫ10 5 cells/ml for WST-8 assay. For the thymidine incorporation assays, 0.5 ml of cell suspension was added per well to 24-well tissue culture plates (Becton Dickinson). For the WST-8 assay, 0.1 ml suspension was added per well to 96-well tissue culture plates (Becton Dickinson). Macrophages were incubated for 2 h at 37°C in a humidified atmosphere of 5% CO 2 in air. Nonadherent cells were then removed by gentle washing with medium. More than 95% of the adherent cells were judged to be macrophages by both Giemsa staining and Latex-particle uptake.
Tritiated Thymidine Incorporation Assay OxLDL (10 mg/ml) was preincubated with P-4 (100 mg/ml) in 0.5 ml of medium for 30 min at 37°C. For analysis of OxLDL-induced macrophage proliferation, macrophages were cultured in medium with the preincubation mixture of OxLDL and P-4 for 96 h without medium change. Macrophage proliferation was determined by the incorporation of [ 3 H]thymidine into cellular DNA. Briefly, 10 ml of 20 mCi/ml methyl[
3 H]thymidine (80 Ci/mmol, Amersham bioscience) were added to each well of 24-well plates for the last 18 h of each experiment. The medium was then aspirated, and cells were washed with ice-cold 10% trichloroacetic acid to precipitate DNA and remove unincorporated labels. Cells were dissolved in 0.1 M NaOH to hydrolyze the acid-insoluble material. Radioactivity was analyzed using a liquid scintillation counter.
WST-8 Growth Assay OxLDL (20 mg/ml) was preincubated with P-4 (50-200 mg/ml) in 0.1 ml of medium for 30 min at 37°C. For analysis of OxLDL-induced macrophage proliferation, macrophages were cultured in medium with the preincubation mixture of OxLDL and P-4 for 96 h without medium change. Macrophage proliferation was determined by the WST-8 [2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-dinitrophenyl)-2H-tetrazolium, monosodium salt] assays using a Cell Counting Kit-8 (Dojindo). Briefly, 10 ml of WST-8/1-methoxy-phenazine methosulfate solution was added to each well of 96-well plates and incubated for 2 h at 37°C. Absorbance at 450 nm was then measured with a multiwell spectrophotometer.
Dissociation-Enhanced Lanthanide Fluorometric Immunoassay (DELFIA) LysoPC extracted from OxLDL (1-4 mg/ml) was preincubated with biotinylated P-21 (2.5 mg/ml) for 15 min at 37°C. The binding assay of P-21 to OxLDL was performed by DELFIA, utilizing lanthanide chelates and time-resolved fluorometry. 25, 26) Rabbit antihuman b-lipoprotein IgG fractions (1 mg/100 ml) were placed in wells of a 96-well microtiter plate and incubated overnight at 4°C. After removing the antibody fluid, the wells were blocked with SuperBlock ® Blocking Buffer in PBS (Pierce). After washing the wells three times with PBS, 10 mg/ml of modified LDLs were added to each well. After incubation for 1 h at 37°C, the plates were washed with PBS. Then 100 ml of biotinylated P-21 or preincubation mixture of LysoPC and biotinylated P-21 were added to each well and incubated for 30 min at 37°C, followed by 100 ml of Eu 3ϩ -labelled streptavidin (Wallac Oy) (1 : 1000 diluted in PBS) for 30 min at room temperature. Plates were washed six times and the bound Eu 3ϩ was dissociated and fluorescence enhanced by incubation with 100 ml of DELFIA enhancement solution (Wallac Oy). After shaking for 5 min, we determined fluorescence using a 1420 ARVOsx DELFIA Research Fluorometer (Wallac Oy) with the standard setting for Eu 3ϩ (excitation wavelength of 340 nm and an emission wavelength of 615 nm).
Binding Assay of P-21 to LysoPC P-21 (2.5 mg/ml) was incubated with 20 ml of 1.25 mCi/ml lysopalmitoyl phos-
]LysoPC, 55.8 mCi/mmol, PerkinElmer) in the absence or presence of 100-fold excess of unlabeled 1-palmitoyl-sn-glycero-3-phosphocholine (palmitoyl-LysoPC, Avanti Polar Lipids, Inc.) in 0.12 ml of PBS for 12 h at 37°C. After incubation, 50 ml of ImmunoPure ® Immobilized Streptavidin beads (Pierce) was added to the reaction mixture and incubated with gentle mixing for 30 min at 25°C. The beads-bound reaction mixture was subsequently rinsed 3 times with 0.5 ml PBS. The radioactivity of the beads was measured in a liquid scintillation counter.
Statistical Analysis Data were evaluated by paired Student's t-test. When the p value was less than 0.05, the difference was considered significant.
RESULTS
Binding Analysis of Asp-Hemolysin-Related Peptides to OxLDL To clarify the minimum amino acid sequence of the Asp-hemolysin-related peptide that is capable of binding to OxLDL, we obtained several synthetic peptides (Table 1) ) and C-terminal a-helix by the Cho-Fasman algorithm and the 3D-1D analysis, respectively. We first examined the binding of these peptides to OxLDL by Western blot analysis using each biotinylated peptide. As shown in Fig. 1 , the incubation of OxLDL with each Asp-hemolysin-related peptide resulted in the formation of an Asphemolysin-related peptide/OxLDL complex with migration corresponding to that of OxLDL alone. The intensity of the OxLDL/Asp-hemolysin-related peptide complex bands by P-21, P-24 and P-29 was greater than that of other peptides. In contrast, the intensity of the OxLDL/Asp-hemolysin-related peptide complex bands by P-7 and P-15 was low. In addition, the peptide corresponding to 32-35 of the Asp-hemolysin amino acid sequence (YKDG, P-4) also formed the peptide/OxLDL complex. Furthermore, we analyzed the interaction between the Asp-hemolysin-related peptide and LDL oxidized at different times by Western blot analysis using biotinylated P-21 and biotinylated P-4. Incubation of the various oxidized samples of LDL with biotinylated P-21 resulted in the formation of a biotinylated P-21/OxLDL complex with a migration corresponding to that of OxLDL alone (Fig. 2A) .
The intensity of the biotinylated P-21/OxLDL complex bands increased as the LDL oxidation progressed. In addition, when biotinylated P-4 incubated with LDL oxidized at different times, the intensity of the biotinylated P-4/OxLDL complex bands also significantly increased as LDL oxidation progressed (Fig. 2B) . However, biotinylated P-21 or P-4/OxLDL complex bands were slightly detected at 0 h oxidized LDL, which is normal LDL (nLDL).
These results indicate that the YKDG sequence of Asp-hemolysin-related peptides is necessary for the binding of these peptides to OxLDL. 
Fig. 2. Binding of P-21 (A) or P-4 (B) to LDL Oxidized at Different Times by Western Blot Analysis
Biotinylated P-21 or P-4 and OxLDL were incubated for 30 min at 37°C and the resultant complexes were separated on 4% native PAGE, transferred to Immobilon P. The membrane was washed and incubated with streptavidin-biotinylated horseradish peroxidase complex and detected by ECL.
Binding of P-4 to Auto-Oxidized LDL
Since the Asphemolysin-related peptide/OxLDL complex band was detected by nLDL, we next examined the binding analysis of biotinylated P-4 to LDL prepared in the presence or absence of BHT as an antioxidative reagent and stored for 14 d at room temperature to auto oxidation. The results in Fig. 3 show that biotinylated P-4 became bound to auto-oxidized LDL as well as nLDL, whereas BHT-containing LDL did not bind to the peptide. Figure 3 also shows that the binding activity of biotinylated P-4 detected auto-oxidized LDL to a greater extent than it did nLDL. The extent of oxidation of LDL prepared without BHT was not significantly different compared with BHT-containing LDL by thiobarbituric acid reactive substances (TBARS) assay (0.18Ϯ0.03 nmol MDA/mg protein and 0.17Ϯ0.04 nmol MDA/mg protein, respectively). Furthermore, the binding of biotinylated P-4 to auto-oxidized LDL was inhibited by unlabelled P-4 in a dose-dependent manner (Fig. 4) .
Effect of P-4 on OxLDL-Induced Macrophage Proliferation To investigate whether or not the P-4 affected the bioactivity of OxLDL, we examined the effect of P-4 as the shortest sequence peptide, which indicated binding to OxLDL on Ox-LDL-induced macrophage proliferation. As shown in Fig. 5A, OxLDL induced [ 3 H]thymidine incorporation into macrophages, which was significantly inhibited by 65.9% with P-4. The effect of P-4 on macrophage proliferation induced by OxLDL was also examined by WST-8 assay. As shown in Fig. 5B , P-4 significantly inhibited OxLDL-induced macrophage proliferation by 67.2%. Furthermore, OxLDL-induced macrophage proliferation activity as measured by the WST-8 assay, which was inhibited by P-4 in a dose-dependent manner (Fig. 6) . In contrast, P-4 alone did not affect either [ 3 H]thymidine incorporation or WST-8 assays (data not shown). These results indicate that OxLDLinduced macrophage proliferation is effectively inhibited by P-4.
Effect of LysoPC on P-21 Binding to OxLDL
We previously demonstrated that Asp-hemolysin directly binds to LysoPC. 19 ) Therefore, we examined the effect of LysoPC extracted from OxLDL on P-21 binding to OxLDL by DELFIA. When biotinylated P-21 was incubated with OxLDL in the presence or absence of LysoPC, the binding of biotinylated P-21 to OxLDL was inhibited by LysoPC from OxLDL in a dose-dependent manner (Fig. 7) . Furthermore, 2184 Vol. 29, No. 11 we analyzed the binding of LysoPC to P-21 by radioimmunoassay using synthetic [ 14 C]LysoPC. As shown in Fig. 8 , when P-21 was incubated with [ 14 C]LysoPC, the P-21 bound radioactivity increased, whereas the presence of 100-fold excess of unlabelled palmitoyl-LysoPC caused a significant inhibition of the binding of [ 
DISCUSSION
OxLDL uptake by macrophages via their scavenger receptor, such as class A, type I and type II macrophage scavenger receptors (MSR-AI/AII), LOX-1, has been reported. It is known that MSR-AI/AII mediates the recognition of a wide range of negatively charged macromolecules including OxLDL, and a charged collagen structure containing a lysine cluster of the receptor specifically interacts with OxLDL. 27) On the other hand, we previously demonstrated that the molecular mechanisms of the OxLDL binding to Asp-hemolysin are distinct from those of the scavenger receptors, such as MSR-AI/AII, LOX-1.
18) Moreover, we recently reported that the Asp-hemolysin-related peptide that consists of 21 amino acid residues, named P-21, inhibits OxLDL-induced macrophage proliferation through binding of P-21 to OxLDL. 20) Therefore, we attempted to identify the amino acid sequence that is required for the binding to OxLDL. The synthesized peptide from 4 to 29 amino acid residues, containing P-21, derived from Asp-hemolysin included a putative a-helix-turn-a-helix or a-helix-coil-a-helix predicted by the Cho-Fasman algorithm and the 3D-1D analysis, respectively. This finding suggests that the region of the b-turn or coil in the Asp-hemolysin-related peptide may be involved in the binding of peptides to OxLDL. In the present study, we demonstrated that all the peptide used for the binding assay bound to OxLDL, and P-21 and P-4 bound to OxLDL significantly increased as LDL oxidation progressed. Furthermore, P-4 inhibited the OxLDL-induced macrophage proliferation in a dose-dependent manner. Therefore, these results clearly indicate that the tetrapeptide, YKDG, is essential for OxLDL binding. However, in western blot analysis, the binding signal of P-7 or P-15 to OxLDL was weak compared with other peptides (Fig. 1) . The isoelectric point of P-15 are alkaline, whereas other peptides are acidic. This difference of isoelectric point between P-15 and other peptides may be involved in the decrease of detection signal of P-15 binds to OxLDL. On the other hand, the reason of the decrease of detection signal of P-7 binds to OxLDL has not been clarified in detail. Further studies are needed to elucidate the issue.
Minimally modified LDL (MM-LDL), prepared by prolonged storage at 4°C for up to 6 months (auto-oxidized LDL) or by treatment with very low concentrations of ferrous ion, shows slight increases in TBARS and in relative electrophoretic mobility. It binds to LDL receptors but not to scavenger receptors, suggesting that chemical and conformational changes in MM-LDL are minimal. 28) These changes in MM-LDL are not fully understood; however, lipid peroxidation is very likely to be involved. MM-LDL has been shown to have many biological activities in vascular cells: it induces the endothelial expression of monocyte chemoattractant protein-1 (MCP-1), 28) tissue factor, 29) and P-selectin. 30 ) A number of studies have suggested that MM-LDL is able to induce probable initial events in the development of atherosclerosis including recruitment of monocytes from the blood stream by the action of MCP-1. In the present study, we demonstrated that the biotinylated P-4 bound to auto-oxidized LDL and its binding activity was greater than that of nLDL prepared without BHT. In addition, the binding of biotinylated P-4 to auto-oxidized LDL was inhibited by unlabelled P-4 in a dose-dependent manner. Furthermore, the preparation of LDL in the presence of BHT as an antioxidant was abolished the binding of biotinylated P-4 to nLDL or auto-oxidized LDL. These results suggest that P-4 is able to recognize extremely slight modifications of LDL, such as auto-oxidized LDL belonging to MM-LDL, and the Asp-hemolysin-related peptide may be a useful tool to investigate the pathophysiological significance of OxLDL. The oxidative modification of LDL is associated with many changes in the chemical composition of LDL, including degradation of apolipoprotein B-100, generation of lipid peroxides and oxysterols, and conversion of PC to LysoPC. 31) LysoPC is generated during LDL oxidation through enzymatic hydrolysis of PC by platelet-activating factor acetylhydrolase, an enzyme that is normally associated with LDL. 32) The known biological activities of OxLDL include chemotactic activity for circulating monocytes, 7, 33) a cytotoxic effect on endothelial cells, 9) induction in endothelial cells of several factors such as granulocyte macrophage colony-stimulating factor, 34) cell adhesion molecules, 35) platelet-derived growth factor and heparin-binding epidermal growth factorlike protein, 36) induction of platelet-derived growth factor in smooth muscle cells, 37) impairment of endothelium-dependent arterial relaxation, 8, 38) and stimulation of platelet aggregation. 39 ) Some of these functions of OxLDL have been induced by LysoPC alone rather than by OxLDL particles. 7, 8, 35, 36) In the present study, we demonstrated that LysoPC extracted from OxLDL inhibited the binding of P-21 to OxLDL in a dose-dependent manner. Furthermore, we indicated that P-21 bound to LysoPC by radioimmunoassay using [ 14 C]LysoPC. These results suggest that LysoPC in OxLDL particles, at least in part, play an important role in the binding of the Asp-hemolysin-related peptide.
In conclusion, we have shown that the YKDG sequence of the Asp-hemolysin-related peptide is essential for the development of the specific binding to OxLDL or LysoPC as a typical lipid moiety of OxLDL. Further study on the binding mechanism between the Asp-hemolysin-related peptide and OxLDL may provide important information on the prevention and treatment of atherosclerosis.
